At STIO  we are committed to innovation and the continuous development of pharmaceutical solutions that address evolving healthcare needs. Our rotating pipeline products represent a dynamic portfolio of cutting-edge therapies that are at various stages of research and development. These products are periodically evaluated and updated to align with market demands, regulatory advancements, and scientific breakthroughs.

Our Focus Areas

Our rotating pipeline includes a diverse range of therapeutic areas, ensuring that we remain at the forefront of medical innovation. Key focus areas include:

• Oncology: Advancing treatments that target various forms of cancer with precision medicine.

• Cardiovascular Diseases: Developing novel therapies for heart-related conditions.

• Neurology: Exploring new solutions for neurodegenerative and psychiatric disorders.

• Infectious Diseases: Addressing emerging and resistant pathogens with next-generation antibiotics and antivirals.

• Rare Diseases: Committed to developing orphan drugs that cater to underserved patient populations.

Why a Rotating Pipeline?

Our dynamic approach ensures that we consistently pursue the most promising drug candidates while adapting to new medical and regulatory landscapes. The rotating pipeline allows us to:

• Prioritize high-impact treatments.

• Redirect resources efficiently toward breakthrough developments.

Stay agile in a rapidly evolving pharmaceutical industry.

•  Esmolol HCL – SLS
•  Zedrof
•  Magneisum Sulfate
• SLS Hedilyte pH 7.4
• Hedilyte pH 5.5